China Biotech Services Holdings Limited (HKG:8037)

Hong Kong · Delayed Price · Currency is HKD

0.6000

+0.0900 (17.65%)

Jun 18, 2026, 3:58 PM HKT

-18.92% (1Y)

Market Cap	585.44M -6.3%
Revenue (ttm)	73.50M +4.2%
Net Income	-68.78M
EPS	-0.07
Shares Out	975.73M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	300,000
Open	0.5200
Previous Close	0.5100
Day's Range	0.5100 - 0.6000
52-Week Range	0.4300 - 1.3300
Beta	-0.79
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About HKG:8037

China Biotech Services Holdings Limited, an investment holding company, provides medical laboratory testing and health check services in the People’s Republic of China and Hong Kong. The company operates through Medical and Health Related Services, Immunotherapy, Pharmaceutical Products, Insurance Brokerage, BNCT, and Others segments. It also engages in the provision of tumor immune cell therapy and health management services; sale and distribution of health related and pharmaceutical products; insurance brokerage services; provision of boron n... [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 1996

Employees 149

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 8037

Full Company Profile

Financial Performance

In 2025, HKG:8037's revenue was 73.50 million, an increase of 4.25% compared to the previous year's 70.51 million. Losses were -68.78 million, -65.29% less than in 2024.

Financial Statements